Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis • Generate • Validate • ComputE • Training • Analysis •Generate • Validate • ComputE • Training • Analysis •Generate • Validate
Innovative Sequences
Infinite possibilities
Learn More
.png)
Cell Type Selectivity
Designed to generate mRNA sequences by employing proprietary algorithms and comprehensive omics data, nCode_Synapse ensures that therapeutic sequences are activated precisely in the cell types of interest, minimizing off-target expression and enhancing therapeutic outcomes.
.png)
Optimized Expression
nCode_Synapse ensures that mRNA sequences are programmed to express therapeutic proteins at optimal levels specifically within the target cell types thereby ensuring maximal therapeutic efficacy while minimizing side effects, making treatments more effective and safer.

Forecasted Immunogenicity
Our dual switch-regulated platform provides unmatched control over the creation of both immunogenic and non-immunogenic RNA sequences enabling exact modulation of immune responses to secure both safety and efficacy.

The NCODE
ECOSYSTEM
At the heart of the mRNA Therapeutic ecosystem, nCode acts as a pivotal partner, driving the process from early research through to pre-clinical stages. We provide comprehensive support in target identification, validation, lead optimization, and preclinical testing. The nCode platform employs an "Intra-Extra Integration" approach, absorbing, generating, validating, computing, and analyzing data to continuously enrich our Synapse model. This approach supports a wide range of applications, integrates digital and physical infrastructure, and is backed by robust informatics, dashboards, reports, and continuous learning, all designed to scale and enhance the efficiency and success of RNA therapeutic development.














